Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients

被引:26
作者
Li, Lin [2 ,5 ,6 ]
Liu, Xu-Ping [3 ,5 ,6 ]
Nie, Ling [2 ,5 ,6 ]
Yu, Ming-Hua [4 ,5 ,6 ]
Zhang, Yue [1 ,5 ,6 ]
Qin, Tie-Jun [1 ,5 ,6 ]
Xiao, Zhi-Jian [1 ,2 ,5 ,6 ]
机构
[1] Chinese Acad Med Sci, Inst Hematol, Dept Clin Hematol, Tianjin 300020, Peoples R China
[2] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
[3] Chinese Acad Med Sci, Inst Hematol, Lab Cytogenet, Tianjin 300020, Peoples R China
[4] Chinese Acad Med Sci, Inst Hematol, Lab Morphol, Tianjin 300020, Peoples R China
[5] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin 300020, Peoples R China
[6] Peking Union Med Coll, Tianjin 300020, Peoples R China
关键词
Myelodysplastic syndromes; Primary; Cytogenetics; Karyotype; WORLD-HEALTH-ORGANIZATION; PROGNOSTIC SCORING SYSTEMS; CLASSIFICATIONS; FAB;
D O I
10.1016/j.leukres.2008.11.021
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Myelodysplastic syndromes (MDS) are a heterogeneous group of myeloid neoplasms. Chromosomal abnormalities have been detected in 40-70% patients with primary MDS and are heterogeneous among patients of different races and from different backgrounds. In the current study, 351 Chinese adult patients with primary MDS were retrospectively analyzed for their chromosomal abnormalities by karyotyping. Among the 237 cases (67.5%) of chromosomal abnormalities, 99 were copy number changes alone (41.7%), 70 were structural abnormalities alone (29.5%), and 68 displayed both of these changes (28.8%). Overall, the frequency of -5/5q-/del(5)(q13-33) was 5.1% in these Chinese MDS patients, which was lower than that in the MDS patients of western countries (8.7-23.4%), and the incidence of 5q- syndrome was only 0.3% in Chinese MDS patients. On the other hand, the frequencies of trisomy 8 (19.1%) and -20/20q-/del(20)(q11-13) (9.4%) were higher than those in western countries (1.2-7.0% and 2.0-3.5%, respectively). Chromosomal translocations were also detected in 31 cases (13.1%) including 12 rare translocations that have not been reported in MDS patients before. In addition, i(17)(q10) was detected in nine cases (3.8%), of which six cases only had this single abnormality. According to the IPSS chromosomal prognostic classification, the incidence of poor-risk karyotypes increased in the advanced WHO subtypes (p < 0.001). Together, we detected the unique cytogenetic features of chromosomal abnormalities and some rare translocations of MDS among Chinese patients. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1194 / 1198
页数:5
相关论文
共 17 条
  • [1] Belli C, 2002, HAEMATOLOGICA, V87, P9
  • [2] World Health Organization classification in combination with cytogenetic markers improves the prognostic stratification of patients with de novo primary myelodysplastic syndromes
    Bernasconi, Paolo
    Klersy, Catherine
    Boni, Marina
    Cavigliano, Paola M.
    Calatroni, Silvia
    Giardini, Ilaria
    Rocca, Barbara
    Zappatore, Rita
    Caresana, Marilena
    Dambruoso, Irene
    Lazzarino, Mario
    Bernasconi, Carlo
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (03) : 193 - 205
  • [3] Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries
    Chen, B
    Zhao, WL
    Jin, J
    Xue, YQ
    Cheng, X
    Chen, XT
    Cui, J
    Chen, ZM
    Cao, Q
    Yang, G
    Yao, Y
    Xia, HL
    Tong, JH
    Li, JM
    Chen, J
    Xiong, SM
    Shen, ZX
    Waxman, S
    Chen, Z
    Chen, SJ
    [J]. LEUKEMIA, 2005, 19 (05) : 767 - 775
  • [4] International scoring system for evaluating prognosis in myelodysplastic syndromes
    Greenberg, P
    Cox, C
    LeBeau, MM
    Fenaux, P
    Morel, P
    Sanz, G
    Sanz, M
    Vallespi, T
    Hamblin, T
    Oscier, D
    Ohyashiki, K
    Toyama, K
    Aul, C
    Mufti, G
    Bennett, J
    [J]. BLOOD, 1997, 89 (06) : 2079 - 2088
  • [5] Myelodysplastic syndromes in Thailand: a retrospective pathologic and clinical analysis of 117 cases
    Intragumtornchai, T
    Prayoonwiwat, W
    Swasdikul, D
    Suwanwela, N
    Chaimongkol, B
    Jootar, S
    Chansung, K
    Chancharunee, S
    Leelasiri, A
    Yoshida, Y
    [J]. LEUKEMIA RESEARCH, 1998, 22 (05) : 453 - 460
  • [6] Application of different prognostic scoring systems and comparison of the FAB and WHO classifications in Korean patients with myelodysplastic syndrome
    Lee, JH
    Lee, JH
    Shin, YR
    Lee, JS
    Kim, WK
    Chi, HS
    Park, CJ
    Seo, EJ
    Lee, KH
    [J]. LEUKEMIA, 2003, 17 (02) : 305 - 313
  • [7] Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications
    Lorand-Metze, I
    Pinheiro, MP
    Ribeiro, E
    de Paula, EV
    Metze, K
    [J]. LEUKEMIA RESEARCH, 2004, 28 (06) : 587 - 594
  • [8] Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes
    Matsuda, A
    Germing, U
    Jinnai, I
    Misumi, M
    Kuendgen, A
    Knipp, S
    Aivado, M
    Iwanaga, M
    Miyazaki, Y
    Tsushima, H
    Sakai, M
    Bessho, M
    Tomonaga, M
    [J]. BLOOD, 2005, 106 (08) : 2633 - 2640
  • [9] Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes:: results of a single-center analysis
    Mueller-Berndorff, H.
    Haas, P. S.
    Kunzmann, R.
    Schulte-Moenting, J.
    Luebbert, M.
    [J]. ANNALS OF HEMATOLOGY, 2006, 85 (08) : 502 - 513
  • [10] Classification and scoring systems in myelodysplastic syndromes:: A retrospective analysis of 311 patients
    Navarro, I.
    Ruiz, M. A.
    Cabello, A.
    Collado, R.
    Ferrer, R.
    Hueso, J.
    Martinez, J.
    Miguel, A.
    Orero, M. T.
    Perez, P.
    Nolasco, A.
    Carbonell, F.
    [J]. LEUKEMIA RESEARCH, 2006, 30 (08) : 971 - 977